The impact of whole body PET FDG-PET on staging of lung cancer.

被引：0
|
作者：
Changlai, SP [1 ]
Schiepers, C [1 ]
Blatt, SA [1 ]
Seltzer, M [1 ]
Hol, CK [1 ]
Dahlbom, M [1 ]
Phleps, ME [1 ]
Gambhir, S [1 ]
Czernin, J [1 ]
机构：
[1] Univ Calif Los Angeles, Med Ctr, Ahmanson Biol Imaging Clin, Los Angeles, CA 90024 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
226
引用
收藏
页码：56P / 56P
页数：1
相关论文
共 50 条
  • [11] FDG-PET in staging and evaluating response to treatment in gastric cancer.
    Herrington, GD
    Storey, DW
    Lord, DJ
    Meikle, SR
    Thompson, JF
    Fulham, MJ
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 541 - 541
  • [12] Comparison of FDG-PET, CT and tumormarkers for staging of testicular cancer.
    Cremerius, U
    Adam, G
    Zimny, M
    Jakse, G
    Buell, U
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 249P - 250P
  • [13] Impact of FDG-PET in staging of non-small cell lung cancer
    Rodríguez-Fernández, A
    Gómez-Río, M
    Ortega, S
    Ramos-Font, C
    Sabatel, G
    Bellon, ME
    Sánchez-Palencia, A
    Llamas-Elvira, JM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S349 - S350
  • [14] FDG-PET and PET/CT in breast cancer staging
    Avril, Norbert
    Mather, Stephen J.
    Roylance, Rebecca
    BREAST CARE, 2007, 2 (06) : 372 - 377
  • [15] Whole-body tumor staging: MRI or FDG-PET/CT?
    Antoch, G
    Vogt, FM
    Bockisch, A
    Ruehm, SG
    RADIOLOGE, 2004, 44 (09): : 882 - 888
  • [16] Impact of FDG-PET on management of patients with colorectal cancer.
    Meta, J
    Valk, P
    Ariannejad, M
    Seltzer, MA
    Wong, C
    Phelps, ME
    Gambhir, SS
    Czernin, J
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 299P - 299P
  • [17] Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma
    Masayuki Sasaki
    Yasuo Kuwabara
    Hirofumi Koga
    Makoto Nakagawa
    Tao Chen
    Kouichirou Kaneko
    Kazutaka Hayashi
    Katsumasa Nakamura
    Kouji Masuda
    Annals of Nuclear Medicine, 2002, 16 : 337 - 345
  • [18] Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma
    Sasaki, M
    Kuwabara, Y
    Koga, H
    Nakagawa, M
    Chen, T
    Kaneko, K
    Hayashi, K
    Nakamura, K
    Masuda, K
    ANNALS OF NUCLEAR MEDICINE, 2002, 16 (05) : 337 - 345
  • [19] Clinical impact of FDG-PET for recurrent ovarian cancer.
    Ebina, Y
    Akashi, D
    Takeda, M
    Watari, H
    Yamamoto, R
    Sakuragi, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 480S - 480S
  • [20] Whole-body tumor staging: MRI or FDG-PET/CT? [Ganzkörpertumorstaging: MRT oder FDG-PET/CT?]
    Antoch G.
    Vogt F.M.
    Bockisch A.
    Ruehm S.G.
    Der Radiologe, 2004, 44 (9): : 882 - 888
12345